Found 169 matching trials
MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma PHASE1 The purpose of this study is to confirm the safety and tolerability of elra...
Show More Location
Nagoya City University Hospital
Learn More & Join Trial
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan N/A The purpose of this study is to evaluate:
* What is the real-world effecti...
Show More Status
Active Not Recruiting
Location
Kaohsiung Chang Gung Memorial Hospital
Learn More & Join Trial
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events PHASE2 The purpose of this study is to identify preventive treatments that can min...
Show More Location
University of California San Francisco
Learn More & Join Trial
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study) PHASE2 The purpose of this study is to see whether combination treatment of Teclis...
Show More Location
University of Miami
Learn More & Join Trial
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis PHASE2 This is a multicenter open-label, phase 2 study in participant with previou...
Show More Status
Active Not Recruiting
Location
South Australia Health
Learn More & Join Trial
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. PHASE2 This Phase II, open-label, multicenter study will evaluate teclistamab in c...
Show More Learn More & Join Trial
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) PHASE2 Multiple myeloma is characterized by a pattern of recurrent relapse and rem...
Show More Learn More & Join Trial
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects PHASE1 The main purpose of the study is to understand the safety and tolerability ...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma PHASE3 The purpose of this study is to evaluate how well JNJ-79635322 works when c...
Show More Learn More & Join Trial
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma PHASE1 This is a single-arm, open-label, phase 1b study evaluating the safety and ...
Show More Location
Froedtert & the Medical College of Wisconsin
Learn More & Join Trial